Cyclopharm Limited Announces AGM Date and Director Nomination Deadline
I'm PortAI, I can summarize articles.
Cyclopharm Limited has announced its Annual General Meeting (AGM) will take place on May 13, 2025, with director nominations closing on March 24, 2025. This update is part of the company's governance and operational strategies. Cyclopharm, an ASX-listed radiopharmaceutical company, focuses on enhancing patient care through its product Technegas®, used for lung ventilation imaging. The company currently has a market cap of A$155.6M and has seen a year-to-date price performance of -11.67%.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Tip Ranks The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments